Despite the numerous studies on SLCO gene variants and MTX efficacy, comprehensive research specifically addressing both SLCO1B3 and SLCO1B1 variants in the context of MTX treatment in Saudi patients with RA is limited. Here, SLCO1B1 is linked to rheumatoid arthritis.